ProPhase Labs, Inc. (Formerly Known as Quigley Corporation)

121 articles about ProPhase Labs, Inc. (Formerly Known as Quigley Corporation)

• ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) to Release First Quarter Results on Monday, May 17

  5/17/2010

• The Quigley Corporation Shareholders Approve Name Change to ProPhase Labs, Inc. (Formerly Known as Quigley Corporation)

  5/6/2010

• The Quigley Corporation Reports Fourth Quarter 2009 Results

  3/25/2010

• The Quigley Corporation And Phosphagenics Limited Form JV to Develop and Market OTC Products

  3/23/2010

• Quigley Corporation CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan

  12/4/2009

• Quigley Corporation Reports Third Quarter 2009 Results

  11/12/2009

• The Quigley Corporation to Announce Second Quarter Results and Host Audio Web Cast

  7/30/2009

• Quigley Corporation Announces Final Results of Quigley Pharma Inc.'s Phase IIb Study

  7/22/2009

• Ted Karkus Named CEO of Quigley Corporation; Robert V. Cuddihy, Jr. Named Chief Operating Officer

  7/17/2009

• Dr. Richard Rosenbloom Resumes Services To The Quigley Corporation's Pharma Subsidiary

  7/10/2009

• Ted Karkus Appointed Interim Chief Executive Officer Of Quigley Corporation

  6/18/2009

• Quigley Corporation: Cold-EEZE(R) Lozenges not Affected by FDA Advisory for Zicam(R) Intra-Nasal Products

  6/17/2009

• Quigley Corporation Exploring Strategic Options Including Sale of Pharmaceutical Division

  5/19/2009

• Quigley Corporation Unexpected Positive Finding Expands Potential for Quigley QR333 Drug for Diabetic Neuropathy; Findings Suggest Possible Disease Modification

  4/30/2009

• Quigley Corporation Reports Fourth Quarter and 2008 Annual Results; Continues To Invest In Pharmaceutical R&D Future

  2/26/2009

• Quigley Corporation Licenses Naturally Derived Compound For Scar Improvement

  2/24/2009

• Quigley Corporation To Consolidate Manufacturing Operations

  2/3/2009

• Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future

  10/30/2008

• Quigley Corporation Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens

  9/16/2008

• Quigley Corporation Names Gerard M. Gleeson to Succeed Retiring George J. Longo as Chief Financial Officer and Director

  8/6/2008